Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Summary statement: utility of molecular marker testing in thyroid cancer.

Yip L, Kebebew E, Milas M, Carty SE, Fahey TJ 3rd, Parangi S, Zeiger MA, Nikiforov YE.

Surgery. 2010 Dec;148(6):1313-5. doi: 10.1016/j.surg.2010.09.023.

2.

Adrenocortical carcinoma: the influence of large vessel extension.

Turbendian HK, Strong VE, Hsu M, Ghossein RA, Fahey TJ 3rd.

Surgery. 2010 Dec;148(6):1057-64; discussion 1064. doi: 10.1016/j.surg.2010.09.024.

PMID:
21134533
3.

Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis.

Zetoune T, Keutgen X, Buitrago D, Aldailami H, Shao H, Mazumdar M, Fahey TJ 3rd, Zarnegar R.

Ann Surg Oncol. 2010 Dec;17(12):3287-93. doi: 10.1245/s10434-010-1137-6. Epub 2010 Jul 2.

PMID:
20596784
4.

Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas.

Wang W, Wang H, Teng X, Wang H, Mao C, Teng R, Zhao W, Cao J, Fahey TJ 3rd, Teng L.

Hum Pathol. 2010 Sep;41(9):1299-309. doi: 10.1016/j.humpath.2010.02.008. Epub 2010 May 14.

PMID:
20471663
5.

Comparison of microarray analysis of fine needle aspirates and tissue specimen in thyroid nodule diagnosis.

Kundel A, Zarnegar R, Kato M, Moo TA, Zhu B, Scognamiglio T, Fahey TJ 3rd.

Diagn Mol Pathol. 2010 Mar;19(1):9-14. doi: 10.1097/PDM.0b013e3181ae870c.

PMID:
20186006
6.

Selenium decreases thyroid cancer cell growth by increasing expression of GADD153 and GADD34.

Kato MA, Finley DJ, Lubitz CC, Zhu B, Moo TA, Loeven MR, Ricci JA, Zarnegar R, Katdare M, Fahey TJ 3rd.

Nutr Cancer. 2010;62(1):66-73. doi: 10.1080/01635580903191569.

PMID:
20043261
7.

World wide what? The quality of information on parathyroid disease available on the Internet.

McGill JF, Moo TA, Kato M, Hoda R, Allendorf JD, Inabnet WB, Fahey TJ 3rd, Brunaud L, Zarnegar R, Lee JA.

Surgery. 2009 Dec;146(6):1123-9. doi: 10.1016/j.surg.2009.09.016.

PMID:
19958939
8.

Molecular markers in thyroid cancer diagnostics.

Kato MA, Fahey TJ 3rd.

Surg Clin North Am. 2009 Oct;89(5):1139-55. doi: 10.1016/j.suc.2009.06.012. Review.

PMID:
19836489
9.
10.

Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma.

Moo TA, Umunna B, Kato M, Butriago D, Kundel A, Lee JA, Zarnegar R, Fahey TJ 3rd.

Ann Surg. 2009 Sep;250(3):403-8. doi: 10.1097/SLA.0b013e3181b3adab.

PMID:
19661784
11.

Identification of borderline thyroid tumors by gene expression array analysis.

Arora N, Scognamiglio T, Lubitz CC, Moo TA, Kato MA, Zhu B, Zarnegar R, Chen YT, Fahey TJ 3rd.

Cancer. 2009 Dec 1;115(23):5421-31. doi: 10.1002/cncr.24616.

12.

Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?

Arora N, Turbendian HK, Kato MA, Moo TA, Zarnegar R, Fahey TJ 3rd.

Thyroid. 2009 May;19(5):473-7. doi: 10.1089/thy.2008.0185.

PMID:
19348582
13.

Computed tomography can guide focused exploration in select patients with primary hyperparathyroidism and negative sestamibi scanning.

Harari A, Zarnegar R, Lee J, Kazam E, Inabnet WB 3rd, Fahey TJ 3rd.

Surgery. 2008 Dec;144(6):970-6; discussion 976-9. doi: 10.1016/j.surg.2008.08.029.

PMID:
19041005
14.

Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma.

Arora N, Turbendian HK, Scognamiglio T, Wagner PL, Goldsmith SJ, Zarnegar R, Fahey TJ 3rd.

Surgery. 2008 Dec;144(6):942-7; discussion 947-8. doi: 10.1016/j.surg.2008.07.023.

PMID:
19041001
15.

The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.

Wagner PL, Moo TA, Arora N, Liu YF, Zarnegar R, Scognamiglio T, Fahey TJ 3rd.

Ann Surg Oncol. 2008 Oct;15(10):2833-41. doi: 10.1245/s10434-008-0064-2. Epub 2008 Aug 12.

PMID:
18696160
16.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

17.

FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma.

Rutherford SC, Andemariam B, Philips SM, Elstrom RL, Chadburn A, Furman RR, Niesvizky R, Martin P, Fahey TJ, Coleman M, Goldsmith SJ, Leonard JP.

Leuk Lymphoma. 2008 Apr;49(4):719-26. doi: 10.1080/10428190801927387.

PMID:
18398739
18.

Do benign thyroid nodules have malignant potential? An evidence-based review.

Arora N, Scognamiglio T, Zhu B, Fahey TJ 3rd.

World J Surg. 2008 Jul;32(7):1237-46. doi: 10.1007/s00268-008-9484-1. Review.

PMID:
18327528
19.

Effect of hospital volume of thyroidectomies on outcomes following substernal thyroidectomy.

Pieracci FM, Fahey TJ 3rd.

World J Surg. 2008 May;32(5):740-6. doi: 10.1007/s00268-007-9347-1.

PMID:
18200430
20.

Supplemental Content

Loading ...
Support Center